The International Aloe Science Council is pleased to announce the ninth annual Chairman Yun-Ho Lee Award of Scientific Merit for outstanding scientific contribution in the field of Aloe research. This year's award will be presented at the 26th Annual Scientific Seminar September 2008 in India.

This award is made possible by a generous grant from Mr. Bill Lee, President and C.E.O. of NamYang Aloe International, Ltd. in honor of his late father, Mr. Yun-Ho Lee. Yun-Ho Lee was an early pioneer in the use of Aloe for cosmetic, personal care and health food supplement products and is attributed to greatly enhancing the rapid growth of the use of Aloe, first in the Pacific Rim, then around the world.

The Chairman Yun-Ho Lee Award of Scientific Merit is given annually to the one scientist who has made an outstanding, original research contribution to the science of Aloe including studies in agriculture, manufacturing, pharmacology, chemistry and biology. The award includes travel expenses to the annual meeting of the IASC and a cash award of $10,000.

   Send your papers to the IASC office. The deadline for submission is July 31, 2008.
   All papers will be blinded and forwarded to IASC's Science & Technology Committee Chairman, Dr. Phil Harvey, which will in turn be sent to his committee to vote on the best scientific paper submitted.

Questions
Please contact the IASC if you have any questions.
(972) 258-8772
Fax (972) 258-8777
e-mail: iasc1@msn.com

Click Here to Print A Submission Form

• Manuscripts should be concisely written in English and typed double-spaced throughout on letter-size or A-4 paper with margins of at least 2.5 cm.
  
• Each manuscript must have a title page, which includes only the title, the authors' names, and laboratory of origin, the name and address of the person to whom proofs should be mailed, and any necessary footnotes. The title should be as short as is consistent with clarity.
  
• Pages should be numbered in succession, the title page being page 1.
  
• Tables and figures should be on separate pages placed at the end of the manuscript.
  
• Footnotes to the text should be used sparingly; where they must be used superscript numbers should indicate their locations. Footnotes should be typed with corresponding numbers on a separate sheet. In Tables, reference to footnotes should be made using superscript letter.
  
• Simple chemical compounds should be named in the text of the Materials and Methods and Results sections by formulae when these can be printed in single horizontal lines of type.
  
• Isotopic specifications should conform to the IUPAC system (Biochem. J. (1975) 145, 1-20).
  
• Drug names should be the official or approved names; trade names or common names may be given in brackets where the drug is first mentioned. The manufacturer's name and address must be given. The doses of the drugs should be given as unit weight/unit body weight, e.g. mmol/kg or mg/kg. Concentrations should be given in terms of molarity (eg. nM or uM), or as unit weight/unit volume solution (eg. mg/l) stating whether the weight refers to the salt or the active component of the drug. The molecular weight, inclusive of water of crystallization, should be stated if doses are given as unit weight.
  

• The IUB Enzyme Commission (EC) number must be quoted with the full name of the enzyme when it is first mentioned in the text. Subsequently the accepted trivial name shall be used, e.g. Full Name: Acetyl-CoA:choline O-acetyltransferase (EC 2.3.1.6.) Trivial Name: Choline acetyltransferase not choline acetylase. For this information the author should refer to Enzyme Nomenclature (1973), Elsevier, Amsterdam.
  
• Authors are requested to follow the IUPHAR Guidelines for Classification of New Receptor Subtypes (see Immunopharmacology, Vol. 30, p. 189 or p. 255).
  
• Symbols for physical units should be restricted to the Systeme Internationale (S.I.) Units. Examples of commonly used symbols can be found in Biochemical Journal 145, 1-20 (1975) and more detailed description, in Quantities, Units and Symbols (1971) The Royal Society, London.
  
• The excessive use of abbreviations in the text is strongly discouraged. In particular, awkward and unfamiliar abbreviations and those intended to express concepts or experimental techniques will not be permitted. In order to aid communication between scientists of different disciplines, authors should only use abbreviations sparingly and should always define the abbreviation when first used by placing it in parentheses after the full term, e.g. fetal bovine serum (FBS).